Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 15.2 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 17.2 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 14.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 10.9 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 13.4 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 14.6 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 17.9 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 16.3 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 0.0 | BCD100624C001 | 14.3 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 0.5 | BCD100624C003 | 8.82 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 1.0 | BCD100624C007 | 16.4 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 2.0 | BCD100624C011 | 11.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 4.0 | BCD100624C015 | 10.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 8.0 | BCD100624C019 | 13.9 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 12.0 | BCD100624C023 | 16.3 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | C | 24.0 | BCD100624C027 | 16.1 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 12.3 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 9.98 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 12.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 12.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 14.7 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 9.45 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 11.9 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 0.5 | BCD100624C004 | 15.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 1.0 | BCD100624C008 | 20.1 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 2.0 | BCD100624C012 | 9.86 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 4.0 | BCD100624C016 | 13.5 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 8.0 | BCD100624C020 | 25.6 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 12.0 | BCD100624C024 | 8.61 | pmol/sample |
| LMFA01030759 | 5,8,11,14,17-eicosapentaenoic acid | 25OH-Chol | 24.0 | BCD100624C028 | 9.26 | pmol/sample |